Suzanne Crowe

Summary

Affiliation: Macfarlane Burnet Institute for Medical Research and Public Health
Country: Australia

Publications

  1. ncbi request reprint Monitoring of human immunodeficiency virus infection in resource-constrained countries
    Suzanne Crowe
    Macfarlane Burnet Institute for Medical Research and Public Health, National Centre for HIV Virology Research, Monash University, Melbourne, Victoria, Australia
    Clin Infect Dis 37:S25-35. 2003
  2. pmc Pathogenicity and immunogenicity of attenuated, nef-deleted HIV-1 strains in vivo
    Paul R Gorry
    Macfarlane Burnet Institute for Medical Research and Public Health, Melbourne, Victoria, Australia
    Retrovirology 4:66. 2007
  3. pmc The macrophage: the intersection between HIV infection and atherosclerosis
    Suzanne M Crowe
    Centre for Virology, Macfarlane Burnet Institute for Medical Research and Public Health, Melbourne 3004, Australia
    J Leukoc Biol 87:589-98. 2010
  4. ncbi request reprint The contribution of monocyte infection and trafficking to viral persistence, and maintenance of the viral reservoir in HIV infection
    Suzanne Crowe
    AIDS Pathogenesis and Clinical Research Programme, The Macfarlane Burnet Institute for Medical Research nad Public Health, Melbourne, Australia
    J Leukoc Biol 74:635-41. 2003
  5. doi request reprint Biological determinants of immune reconstitution in HIV-infected patients receiving antiretroviral therapy: the role of interleukin 7 and interleukin 7 receptor α and microbial translocation
    Reena Rajasuriar
    Department of Medicine, Monash University, Burnet Institute, University of Melbourne, Melbourne, Australia
    J Infect Dis 202:1254-64. 2010
  6. doi request reprint Culture of HIV in monocytes and macrophages
    Suzanne Crowe
    Macfarlane Burnet Institute for Medical Research and Monash University, Melbourne, Australia
    Curr Protoc Immunol . 2004
  7. pmc The raft-promoting property of virion-associated cholesterol, but not the presence of virion-associated Brij 98 rafts, is a determinant of human immunodeficiency virus type 1 infectivity
    Shahan Campbell
    Macfarlane Burnet Institute for Medical Research and Public Health, Cnr Punt and Commercial Roads, Melbourne 3004, Victoria, Australia
    J Virol 78:10556-65. 2004
  8. ncbi request reprint Prevalence and characterization of lamivudine-resistant hepatitis B virus mutations in HIV-HBV co-infected individuals
    Louise Cooley
    Victorian Infectious Diseases Reference Laboratory, North Melbourne, Victoria, Australia
    AIDS 17:1649-57. 2003
  9. ncbi request reprint Limited evolution of HIV antiretroviral drug resistance-associated mutations during the performance of drug resistance testing
    Chris Birch
    Victorian Infectioud Diseases Reference Laboratory, North Melbourne, Australia
    J Acquir Immune Defic Syndr 32:57-61. 2003
  10. ncbi request reprint An inexpensive, simple, and manual method of CD4 T-cell quantitation in HIV-infected individuals for use in developing countries
    Pachamuthu Balakrishnan
    YRG Centre for AIDS Research and Education, Voluntary Health Services, Taramani, Chennai, India
    J Acquir Immune Defic Syndr 36:1006-10. 2004

Collaborators

Detail Information

Publications10

  1. ncbi request reprint Monitoring of human immunodeficiency virus infection in resource-constrained countries
    Suzanne Crowe
    Macfarlane Burnet Institute for Medical Research and Public Health, National Centre for HIV Virology Research, Monash University, Melbourne, Victoria, Australia
    Clin Infect Dis 37:S25-35. 2003
    ..Other surrogate markers, such as beta2-microglobulin, are not suitable for routine monitoring of HIV infection. This review discusses the above assays and their role in addition to clinical monitoring in resource-constrained countries...
  2. pmc Pathogenicity and immunogenicity of attenuated, nef-deleted HIV-1 strains in vivo
    Paul R Gorry
    Macfarlane Burnet Institute for Medical Research and Public Health, Melbourne, Victoria, Australia
    Retrovirology 4:66. 2007
    ....
  3. pmc The macrophage: the intersection between HIV infection and atherosclerosis
    Suzanne M Crowe
    Centre for Virology, Macfarlane Burnet Institute for Medical Research and Public Health, Melbourne 3004, Australia
    J Leukoc Biol 87:589-98. 2010
    ..In this review, the central role of monocytes/macrophages in HIV-related CAD and the importance of inflammation and cholesterol metabolism are discussed...
  4. ncbi request reprint The contribution of monocyte infection and trafficking to viral persistence, and maintenance of the viral reservoir in HIV infection
    Suzanne Crowe
    AIDS Pathogenesis and Clinical Research Programme, The Macfarlane Burnet Institute for Medical Research nad Public Health, Melbourne, Australia
    J Leukoc Biol 74:635-41. 2003
    ..This review provides an evaluation of the contribution of monocytes to HIV-1 persistence and the HIV-1 reservoir, essential for the effective design of therapeutic eradication strategies...
  5. doi request reprint Biological determinants of immune reconstitution in HIV-infected patients receiving antiretroviral therapy: the role of interleukin 7 and interleukin 7 receptor α and microbial translocation
    Reena Rajasuriar
    Department of Medicine, Monash University, Burnet Institute, University of Melbourne, Melbourne, Australia
    J Infect Dis 202:1254-64. 2010
    ..We hypothesized that residual immune activation and polymorphisms in the interleukin 7 (IL-7) receptor α (IL-7Rα) gene were important for immune recovery...
  6. doi request reprint Culture of HIV in monocytes and macrophages
    Suzanne Crowe
    Macfarlane Burnet Institute for Medical Research and Monash University, Melbourne, Australia
    Curr Protoc Immunol . 2004
    ..The unit also provides methods for expanding M-tropic primary isolates of HIV and determining the 50% tissue culture infectious dose (TCID50) of HIV stocks...
  7. pmc The raft-promoting property of virion-associated cholesterol, but not the presence of virion-associated Brij 98 rafts, is a determinant of human immunodeficiency virus type 1 infectivity
    Shahan Campbell
    Macfarlane Burnet Institute for Medical Research and Public Health, Cnr Punt and Commercial Roads, Melbourne 3004, Victoria, Australia
    J Virol 78:10556-65. 2004
    ..Our data provide the first direct assessment of virion-associated Brij 98 rafts in retroviral replication and illustrate the importance of the raft-promoting property of virion-associated cholesterol in HIV-1 replication...
  8. ncbi request reprint Prevalence and characterization of lamivudine-resistant hepatitis B virus mutations in HIV-HBV co-infected individuals
    Louise Cooley
    Victorian Infectious Diseases Reference Laboratory, North Melbourne, Victoria, Australia
    AIDS 17:1649-57. 2003
    ....
  9. ncbi request reprint Limited evolution of HIV antiretroviral drug resistance-associated mutations during the performance of drug resistance testing
    Chris Birch
    Victorian Infectioud Diseases Reference Laboratory, North Melbourne, Australia
    J Acquir Immune Defic Syndr 32:57-61. 2003
    ..02), however. In general, our results suggest that patients should continue current therapy until test results are available. A few patients would be expected to gain ARV drug-associated resistance mutations during this time, however...
  10. ncbi request reprint An inexpensive, simple, and manual method of CD4 T-cell quantitation in HIV-infected individuals for use in developing countries
    Pachamuthu Balakrishnan
    YRG Centre for AIDS Research and Education, Voluntary Health Services, Taramani, Chennai, India
    J Acquir Immune Defic Syndr 36:1006-10. 2004
    ..Hence, the cytosphere assay can be an alternate to flow cytometry for the estimation of CD4+ T-lymphocyte counts, especially in resource-poor settings of developing countries, for monitoring HIV progression and response to therapy...